======= CLCF1 =======
== Gene Information ==
* **Official Symbol**: CLCF1
* **Official Name**: cardiotrophin like cytokine factor 1
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=23529|23529]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9UBD9|Q9UBD9]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=CLCF1&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20CLCF1|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/607672|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: This gene is a member of the glycoprotein (gp)130 cytokine family and encodes cardiotrophin-like cytokine factor 1 (CLCF1). CLCF1 forms a heterodimer complex with cytokine receptor-like factor 1 (CRLF1). This dimer competes with ciliary neurotrophic factor (CNTF) for binding to the ciliary neurotrophic factor receptor (CNTFR) complex, and activates the Jak-STAT signaling cascade. CLCF1 can be actively secreted from cells by forming a complex with soluble type I CRLF1 or soluble CNTFR. CLCF1 is a potent neurotrophic factor, B-cell stimulatory agent and neuroendocrine modulator of pituitary corticotroph function. Defects in CLCF1 cause cold-induced sweating syndrome 2 (CISS2). This syndrome is characterized by a profuse sweating after exposure to cold as well as congenital physical abnormalities of the head and spine. Alternative splicing results in multiple transcript variants encoding distinct isoforms.[provided by RefSeq, Oct 2009].
* **UniProt Summary**: Cytokine with B-cell stimulating capability. Binds to and activates the ILST/gp130 receptor. {ECO:0000269|PubMed:10448081, ECO:0000269|PubMed:10500198}.
|PRF|
|CRLF-CLCF1 complex|
|CNTFR-CLCF1 complex|
|positive regulation of isotype switching to IgE isotypes|
|ciliary neurotrophic factor receptor binding|
|regulation of isotype switching to IgE isotypes|
|positive regulation of astrocyte differentiation|
|positive regulation of isotype switching|
|regulation of astrocyte differentiation|
|regulation of isotype switching|
|positive regulation of immunoglobulin mediated immune response|
|positive regulation of B cell mediated immunity|
|receptor signaling pathway via JAK-STAT|
|positive regulation of DNA recombination|
|receptor signaling pathway via STAT|
|positive regulation of B cell proliferation|
|positive regulation of glial cell differentiation|
|positive regulation of immunoglobulin production|
|regulation of B cell mediated immunity|
|regulation of immunoglobulin mediated immune response|
|regulation of B cell proliferation|
|regulation of immunoglobulin production|
|positive regulation of tyrosine phosphorylation of STAT protein|
|regulation of glial cell differentiation|
|positive regulation of gliogenesis|
|regulation of tyrosine phosphorylation of STAT protein|
|positive regulation of receptor signaling pathway via JAK-STAT|
|positive regulation of receptor signaling pathway via STAT|
|positive regulation of production of molecular mediator of immune response|
|positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains|
|regulation of DNA recombination|
|positive regulation of lymphocyte mediated immunity|
|positive regulation of adaptive immune response|
|B cell differentiation|
|regulation of gliogenesis|
|regulation of receptor signaling pathway via JAK-STAT|
|positive regulation of lymphocyte proliferation|
|positive regulation of mononuclear cell proliferation|
|positive regulation of leukocyte mediated immunity|
|regulation of receptor signaling pathway via STAT|
|positive regulation of leukocyte proliferation|
|regulation of production of molecular mediator of immune response|
|regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains|
|negative regulation of neuron apoptotic process|
|regulation of lymphocyte mediated immunity|
|B cell activation|
|regulation of adaptive immune response|
|growth factor activity|
|positive regulation of B cell activation|
|cytokine activity|
|positive regulation of peptidyl-tyrosine phosphorylation|
|positive regulation of DNA metabolic process|
|regulation of leukocyte mediated immunity|
|regulation of neuron apoptotic process|
|negative regulation of neuron death|
|regulation of B cell activation|
|regulation of lymphocyte proliferation|
|regulation of mononuclear cell proliferation|
|positive regulation of immune effector process|
|regulation of leukocyte proliferation|
|lymphocyte differentiation|
|regulation of peptidyl-tyrosine phosphorylation|
|regulation of neuron death|
|leukocyte differentiation|
|signaling receptor binding|
|regulation of DNA metabolic process|
|positive regulation of lymphocyte activation|
|lymphocyte activation|
|positive regulation of leukocyte activation|
|positive regulation of cell activation|
|regulation of immune effector process|
|positive regulation of neurogenesis|
|protein heterodimerization activity|
|regulation of lymphocyte activation|
|positive regulation of nervous system development|
|positive regulation of cell development|
|hemopoiesis|
|regulation of leukocyte activation|
|hematopoietic or lymphoid organ development|
|regulation of cell activation|
|immune system development|
|cytokine-mediated signaling pathway|
|regulation of neurogenesis|
|positive regulation of immune response|
|negative regulation of apoptotic process|
|negative regulation of programmed cell death|
|positive regulation of cell population proliferation|
|regulation of nervous system development|
|leukocyte activation|
|regulation of cell development|
|positive regulation of cell differentiation|
|negative regulation of cell death|
|cellular response to cytokine stimulus|
|positive regulation of protein phosphorylation|
|positive regulation of phosphorylation|
|cell activation|
|response to cytokine|
|positive regulation of phosphorus metabolic process|
|positive regulation of phosphate metabolic process|
|positive regulation of immune system process|
|regulation of immune response|
|positive regulation of protein modification process|
|positive regulation of developmental process|
|regulation of protein phosphorylation|
|generation of neurons|
|regulation of apoptotic process|
|regulation of programmed cell death|
|regulation of phosphorylation|
|positive regulation of cellular protein metabolic process|
|regulation of cell population proliferation|
|neurogenesis|
|regulation of immune system process|
|positive regulation of signal transduction|
|regulation of cell death|
|positive regulation of protein metabolic process|
|positive regulation of multicellular organismal process|
|regulation of phosphate metabolic process|
|regulation of phosphorus metabolic process|
|regulation of cell differentiation|
|positive regulation of cell communication|
|positive regulation of signaling|
|regulation of protein modification process|
|positive regulation of nucleobase-containing compound metabolic process|
|extracellular region|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp393|Resminostat 0.5μM R07 exp393]]|1.78|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 4305
* **Expression level (log2 read counts)**: -2.9
{{:chemogenomics:nalm6 dist.png?nolink |}}